Pacific Biosciences of California Shares Down 26.5% Since SmarTrend's Sell Call (PACB)

SmarTrend identified a Downtrend for Pacific Biosciences of California (NASDAQ:PACB) on February 5th, 2015 at $6.90. In approximately 7 months, Pacific Biosciences of California has returned 26.47%...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.